{"id":"NCT00045032","sponsor":"Hoffmann-La Roche","briefTitle":"Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer","officialTitle":"A Randomized Three-Arm, Multicenter Comparison of 1 Year and 2 Years of Herceptin Versus No Herceptin in Women With HER2-Positive Primary Breast Cancer Who Have Completed Adjuvant Chemotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2001-11","primaryCompletion":"2005-03","completion":"2015-06","firstPosted":"2003-01-27","resultsPosted":"2017-04-27","lastUpdate":"2017-04-27"},"enrollment":5099,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer"],"interventions":[{"type":"DRUG","name":"Herceptin","otherNames":["Trastuzumab"]},{"type":"DRUG","name":"Herceptin","otherNames":["Trastuzumab"]}],"arms":[{"label":"Observation Arm","type":"NO_INTERVENTION"},{"label":"Herceptin 1-Year Arm","type":"EXPERIMENTAL"},{"label":"Herceptin 2-Year Arm","type":"EXPERIMENTAL"}],"summary":"The purpose of this trial is to evaluate Herceptin treatment for 1 year and 2 years (versus observation/no Herceptin) in women with HER2-overexpressing primary breast cancer who have completed (neo-)adjuvant systemic chemotherapy, definitive surgery, and radiotherapy, if applicable. Efficacy and safety will be assessed for 10 years from randomization for each participant. All participants will continue to be followed for survival until 10 years after enrollment of the last participant.","primaryOutcome":{"measure":"Percentage of Participants With Disease-Free Survival (DFS) Events in Herceptin 1-Year Arm Compared to Observation: 1-Year Median Follow-Up","timeFrame":"From Baseline until time of event (median of 1 year)","effectByArm":[{"arm":"Observation Arm","deltaMin":12.9,"sd":null},{"arm":"Herceptin 1-Year Arm","deltaMin":7.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":13},"locations":{"siteCount":203,"countries":["Argentina","Australia","Austria","Belgium","Brazil","Canada","Chile","China","Colombia","Croatia","Denmark","France","Germany","Greece","Guatemala","Hong Kong","Hungary","Ireland","Israel","Italy","Japan","Netherlands","Poland","Portugal","Russia","Singapore","South Africa","South Korea","Spain","Sweden","Switzerland","Thailand","United Kingdom"]},"refs":{"pmids":["18757259","17661170","21354370","20530280","19364966","18296421","17208639","17646669","16236737","40175431","28379421","28215665","27100299","26101239","24912899","23894039","23871490","23589556"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":143,"n":1744},"commonTop":["Arthralgia","Fatigue","Headache","Nasopharyngitis","Hot flush"]}}